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When I wrote “Navigating Between Stealth Advocacy and Unconscious Dogmatism: The Challenge of Researching the Norms, Politics and Power 
of Global Health,”1 my primary intention was to fuel the 
interdisciplinary dialogue on norms, politics, and power that 
had been started in this journal by others. Considering the five 
insightful comments,2-6 responding to my article, I think I can 
claim at least that: the dialogue continues, as it should.
As I borrowed the title for this response from Ilona Kickbusch’s 
comment, let me start there. I fully agree with Kickbusch when 
she writes that “[p]olitics play a central part in determining 
health and development outcomes, health is to a large extent a 
political choice.”4 And I would argue that it is even more true for 
global health. At the national level, there are nascent examples 
of a division of labour between ‘politics’ and ‘technocrats.’ 
The best, or best-known, example of which is the National 
Institute for Health and Care Excellence (NICE) in the United 
Kingdom. NICE’s staff and scholars quite often claim that 
they make recommendations (to the National Health Service 
[NHS], about the adoption of new healthcare technology), on 
the basis of empirical evidence only. That may be true, but 
NICE operates within a political framework, circumscribed by 
politicians. In short: politicians decide, first, that all additional 
life years are of equal worth, and, second, how big or small the 
budget of the NHS is; then the NICE technocrats can calculate 
how the given budget can produce maximum results.
Is this the ideal division of labour between politicians and 
technocrats? Perhaps it is. But even in the United Kingdom, it 
does not always work. When NICE consistently recommended 
against the adoption of new cancer drugs, of which the added 
value (in comparison with other options) was questionable, 
the United Kingdom decided to create a Cancer Drug Fund, 
setting aside a particular budget for the treatment of people 
with cancer. Politicians thus overruled the technocrats. Given 
that the Cancer Drug Fund is being ‘taken over’ by NICE, it 
may be the exception that confirms the general rule.7 Or it may 
indicate that when ‘the people’ perceive that a case is deeply 
unjust – namely, the availability of new cancer drugs being 
restricted to the wealthier part of the population only – no 
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amount of technocratic argument will change their minds, 
and politicians are ‘obliged’ to interfere. 
More importantly, the existence of NICE, and how it functions, 
illustrates how politics and technocracy are deeply entangled 
at the international or global level. At the global level, there 
is no institution in a position to play the technocratic role of 
NICE. And even if we had one – arguably, the World Health 
Organization (WHO) could assume this role – at the global 
level, we do not have the equivalent of the UK Parliament, 
that sets the political framework for NICE. It would be nice – 
pun intended – if we could have an international agreement 
on a US$86 per person per year healthcare financing floor, for 
which national governments and the international community 
would assume shared responsibility for financing,8 and then 
have the WHO make recommendations on how to allocate 
it. But until we have such an agreement, the suggestion of 
adopting it is inevitably a political act (and so is any global 
health recommendation that is based on assumptions of 
available resources). To be clear: I do not think that politics 
in global health are bad, and I am very aware of my own 
political role (and its limitations) as a global health scholar: I 
think politics are inevitable, but prefer open and transparent 
politics over stealth politics; I prefer conscious politics over 
unconscious politics.
This being written, I do believe that there is an important 
distinction between, on the one hand, being political and 
acting upon internationally agreed norms, and on the other 
hand, being political and acting upon one’s own normative 
beliefs. For example, the two essential international human 
rights treaties – namely the International Covenant on Civil 
and Political Rights and the International Covenant on 
Economic, Social and Cultural Rights – are far too state-
centred for my personal cosmopolitan taste. If human rights 
are rights one has because of being part of humanity, their 
realisation should not be as dependent on the national 
resources of the state in which one resides. For my personal 
taste, the $86 per person per year healthcare financing floor 
is not good enough – it should be higher. But while I am 
comfortable saying, as a lawyer, that the US$86 per person per 
year healthcare financing floor is grounded in international 
human rights law, I find it more difficult to argue that 
international human rights law demands a floor of about 
$500 per person per year. From a global health perspective, 
spending at least $500 per person per year on healthcare in 
all countries would be far more efficient than spending $86 
in some countries and $8600 in some other countries. And 
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from a cosmopolitan perspective, all human life years have 
equal value, so spending at least $500 per person per year on 
healthcare in all countries would have my vote. But a $86 per 
person per year healthcare financing floor would be progress, 
and it is grounded in international human rights law, so I limit 
my ‘claim’ to that.
Which brings me to the comments by Clemet Askheim, 
Kristin Heggen, and Eivind Engebretsen,2 and by Lisa 
Forman.3 Although formulated in very different ways, the 
critiques of Askheim et al and of Forman point at a similar 
issue. Is it not naïve to think that a rational (scholarly) analysis 
of international human rights law will bring about a rational 
consensus and thus progress, without political conflicts?2 
Would such a scholarly analysis not obscure the unseen 
norms and powers of global health; would it not obscure the 
“primary mechanism by which power sustains and reinforces 
itself ”?3 In my defense: I never wrote that a scholarly analysis 
of international human rights law, and its integration in 
global health scholarship, would somehow ‘solve the problem’ 
in itself. But I may have implied it. So, to be clear: I have no 
hopes whatsoever that a scholarly analysis of international 
human rights law will suddenly convince the political 
leaders of all 200 or so members of the United Nations that 
a $86 per person per year healthcare financing floor, with 
shared national and international responsibility, should be 
included in the Sustainable Development Goals or any other 
declaration of that kind. My only hope is that the $86 figure 
will highlight the truly scandalous nature of all the human 
deaths and suffering that could be avoided, if only states acted 
upon the commitments they made in international human 
rights treaties. And, by highlighting the truly scandalous 
nature of all the human deaths and suffering that could be 
avoided if only states acted upon their promises, I hope it can 
fuel political struggle and unveil the “primary mechanism by 
which power sustains and reinforces itself ”3 and that makes 
us – global health scholars – look for solutions that fit into $10 
budgets, solutions which we know are excluding people (like 
user fees) and suboptimal (like focusing on prevention when 
prevention and treatment are the only appropriate solution).
That brings me to Robert Marten’s comment. He is right: the 
common definition(s) of global health, or lack thereof, yield 
power. As I highlighted in my original essay, some definitions 
of global health are explicitly normative, and contain at 
least elements of global health justice, like “achieving equity 
in health for all people worldwide,”9 or “promoting health 
for all.”10 I have argued elsewhere that these definitions 
contain a certain degree of wishful thinking, and that a more 
descriptive definition of global health would probably focus 
more on the enlightened self-interest element in international 
cooperation for health.11 Nevertheless, at the risk of confusing 
our audiences, I would prefer to stick to or adopt the more 
normative definition, if only to keep ourselves aware of what 
global health could be and should be about – as long as we do 
not make ourselves believe that the reality of global health is 
equitable in any way.
Last but not least, Johanna Hanefeld’s comment points out the 
importance of global governance, for and of health, as a field 
for research and study.6 I can only agree. If we can accept that, 
as global health scholars, we are inevitably politicians and 
technocrats at the same time, it should be self-evident that 
we need a better understanding of the political arena we are 
part of – and that will indeed require “substantial resources 
and investment.”6 But first and foremost, it will require an 
interdisciplinary dialogue, including the social sciences and 
humanities. 
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